Clinical trials - Press Releases

Date	Title	Company
09-Apr-2020	PFIZER AND THE PFIZER FOUNDATION DONATE $40 MILLION IN CHARITABLE GRANTS, EXPAND PRODUCT ACCESS AND MOBILIZE COLLEAGUES TO COMBAT COVID-19 PANDEMIC	Pfizer
09-Apr-2020	New $35 Co-Pay Now Available Through Lilly Insulin Value Program in Response to COVID-19 Crisis in U.S.	Eli Lilly and Company
09-Apr-2020	Gilead Completes Acquisition of Forty Seven, Inc.	Gilead Sciences
09-Apr-2020	Gilead Sciences and Second Genome Announce Strategic Collaboration in Biomarker and Inflammatory Bowel Disease Drug Discovery	Gilead Sciences
09-Apr-2020	Moderna to Host Virtual Vaccines Day on April 14, 2020	Moderna
09-Apr-2020	Belgium and Canada provide funding boost for CEPI’s COVID-19 vaccine research	CEPI
09-Apr-2020	Roche provides regulatory update on risdiplam for the treatment of spinal muscular atrophy (SMA)	Roche
09-Apr-2020	Volunteer laboratory network launched to expand Covid-19 testing for key workers	Covid-19 Volunteer Testing Network
08-Apr-2020	Celltrion Healthcare secure 300 COVID-19 antibody candidates in efforts to develop antiviral	Celltrion Healthcare
08-Apr-2020	Santhera Enters into Equity-linked Financing to Provide up to CHF 12 million with the Option to Increase to up to CHF 24 million	Santhera
08-Apr-2020	Biovica initiates a collaboration with Mayo Clinic to study DiviTum® for the on-treatment monitoring of metastatic breast cancer patients receiving CDK 4/6 inhibitors	Biovica
08-Apr-2020	90TEN acquired by Envision Pharma Group	Envision Pharma Group
08-Apr-2020	Immutep’s partner, EOC Pharma, to continue advancing Efti in breast cancer	Immutep
08-Apr-2020	Chiesi Group increases support measures and announces new funds for employees, patients and healthcare providers in response to COVID-19 pandemic	Chiesi Group
08-Apr-2020	Quell Therapeutics Enters a Collaborative Research Agreement with the Hannover Medical School	Quell Therapeutics
08-Apr-2020	Réf. DC 058(2020) COVID-19: How to protect yourself from falsified medical products?	MEDICRIME Committee
08-Apr-2020	Lamellar Biomedical launches program designed to prevent the severe respiratory effects of COVID-19, using its unique LAMELLASOME™ Technology	Lamellar Biomedical
08-Apr-2020	The Life Sciences Sector Post-Brexit (So Far)	UK life sciences
08-Apr-2020	Amphista Therapeutics raises $7.5m Series A round to advance targeted protein degradation assets in cancer	Amphista Therapeutics
08-Apr-2020	Santhera Enters into Equity-linked Financing to Provide up to CHF 12 million with the Option to Increase to up to CHF 24 million	Santhera Pharmaceuticals